Literature DB >> 7907730

Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism.

B J van der Mast1, N Hornstra, M B Ruigrok, F H Claas, J J van Rood, E L Lagaaij.   

Abstract

Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare but hazardous complication caused by transfusion of leucocyte-containing blood. It is not clear why some patients are at risk for TA-GVHD, but others are not. We studied TA-GVHD in immunocompetent individuals by looking at donor-anti-host reactivity after transfusion of leucocyte-containing blood. We tested reactivity in 62 donor-recipient combinations in vitro before and at different times after blood transfusion with mixed lymphocyte culture. One patient was studied in more detail. Reactivity of blood donors against hosts gradually decreased after blood transfusion. This decrease significantly correlated with time (p < 0.001). Studies in a single patient showed that absence of donor-host reactivity was due to host T cells that inhibited the response. These data indicate that an active mechanism exists in immunocompetent individuals which inhibits the graft-versus-host reaction of the donor against the host. This mechanism might be exploited in organ transplantation by pre-transplant blood transfer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907730     DOI: 10.1016/s0140-6736(94)91836-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  2 in total

1.  Transfusion-associated graft-versus-host disease in an immunocompetent individual following cardiac surgery.

Authors:  Kivanc Serefhanoglu; Hale Turan; Tonguc Saba; Ismail Ozer; Emine Tosun; Hande Arslan
Journal:  J Natl Med Assoc       Date:  2005-03       Impact factor: 1.798

2.  Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.

Authors:  Lucas Sacchini Del Lama; Evamberto Garcia de Góes; Paulo César Dias Petchevist; Edson Lara Moretto; José Carlos Borges; Dimas Tadeu Covas; Adelaide de Almeida
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.